REBECCA LYNN FLORA APRN
Prescription History 1568744530
Nurse Practitioner in Covington, KY


Quality Rating: 90.38 out of 100 score

NPI Status: Active since September 15, 2011

Contact Information

1500 JAMES SIMPSON JR WAY
SUITE 301
COVINGTON, KY
ZIP 41011
Phone: (859) 655-8910
Fax: (859) 655-8911

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for REBECCA LYNN FLORA APRN, an active Nurse Practitioner specialist practicing in Covington, KY. Our medical registry currently tracks 71 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 4,110 documented patient claims. Among these therapy options, the most frequently utilized medication is Levothyroxine Sodium, which accounts for 363 claims alone.


Alendronate Sodium

Generic Formulation: Alendronate SodiumSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 13
30-Day Fills 31.0
Days Supply 924
KY State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills85.3
Peer Average Days Supply2,518
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 69.0% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $135.73 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.44

State Avg Cost Per Claim

$8.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.

Therapeutic Applications

Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates.

Amlodipine Besylate

Generic Formulation: Amlodipine BesylateSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 27
30-Day Fills 67.3
Days Supply 2,020
KY State Average Benchmarks
Peer Average Claims148.0
Peer Average 30-Day Fills327.7
Peer Average Days Supply9,763
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 81.8% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $125.61 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.65

State Avg Cost Per Claim

$6.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.

Therapeutic Applications

Amlodipine is used with or without other medications to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Amlodipine belongs to a class of drugs known as calcium channel blockers. It works by relaxing blood vessels so blood can flow more easily. Amlodipine is also used to prevent certain types of chest pain (angina). It may help to increase your ability to exercise and decrease the frequency of angina attacks. It should not be used to treat attacks of chest pain when they occur. Use other medications (such as sublingual nitroglycerin) to relieve attacks of chest pain as directed by your doctor.

Atorvastatin Calcium

Generic Formulation: Atorvastatin CalciumSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 163
30-Day Fills 451.0
Days Supply 13,510
KY State Average Benchmarks
Peer Average Claims188.0
Peer Average 30-Day Fills421.0
Peer Average Days Supply12,532
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,799.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.04

State Avg Cost Per Claim

$11.12

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

Therapeutic Applications

Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Basaglar Kwikpen U-100

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 62
30-Day Fills 122.6
Days Supply 3,673
KY State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills36.5
Peer Average Days Supply971
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 148.0% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $34,482.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$556.18

State Avg Cost Per Claim

$464.73

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Bydureon Bcise

Generic Formulation: Exenatide MicrospheresSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 17
30-Day Fills 24.2
Days Supply 700
KY State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills24.4
Peer Average Days Supply704
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $21,583.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,269.64

State Avg Cost Per Claim

$1,123.25

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Exenatide is used either alone or with other medications, and with a proper diet and exercise program, to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Exenatide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high sugar (such as after a meal) and decreasing the amount of sugar your liver makes. Exenatide is not a substitute for insulin if you require insulin treatment.

Comfort Ez Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 20
30-Day Fills 25.6
Days Supply 755
KY State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills30.2
Peer Average Days Supply870
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,153.35 across this reporting matrix range.

Provider Avg Cost Per Claim

$107.67

State Avg Cost Per Claim

$111.57

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Droplet Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 84
30-Day Fills 191.5
Days Supply 5,646
KY State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills54.7
Peer Average Days Supply1,638
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 342.1% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,141.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$85.02

State Avg Cost Per Claim

$84.97

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ezetimibe

Generic Formulation: EzetimibeSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 48
30-Day Fills 130.0
Days Supply 3,900
KY State Average Benchmarks
Peer Average Claims43.0
Peer Average 30-Day Fills96.1
Peer Average Days Supply2,867
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,895.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$39.48

State Avg Cost Per Claim

$60.67

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS B in the treatment of HYPERLIPIDEMIAS.

Therapeutic Applications

Ezetimibe is used along with a low cholesterol/low fat diet and exercise to help lower cholesterol in the blood. Ezetimibe may be used alone or with other drugs (such as statins or fibrates). Ezetimibe works by reducing the amount of cholesterol your body absorbs from your diet. Reducing cholesterol may help prevent strokes and heart attacks.

Farxiga

Generic Formulation: Dapagliflozin PropanediolSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 91
30-Day Fills 222.7
Days Supply 6,657
KY State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills61.4
Peer Average Days Supply1,807
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 139.5% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $131,060.48 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,440.23

State Avg Cost Per Claim

$913.26

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys.

Fenofibrate

Generic Formulation: Fenofibrate NanocrystallizedSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 27
30-Day Fills 82.3
Days Supply 2,470
KY State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills54.0
Peer Average Days Supply1,603
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,482.82 across this reporting matrix range.

Provider Avg Cost Per Claim

$54.92

State Avg Cost Per Claim

$41.58

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood.

Therapeutic Applications

Fenofibrate is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It works by increasing the natural substance (enzyme) that breaks down fats in the blood. Fenofibrate belongs to a group of drugs known as fibrates. Lowering triglycerides in people with very high triglyceride blood levels may decrease the risk of pancreas disease (pancreatitis). However, fenofibrate might not lower your risk of a heart attack or stroke. Talk to your doctor about the risks and benefits of fenofibrate. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Fenofibrate

Generic Formulation: FenofibrateSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 13
30-Day Fills 39.0
Days Supply 1,170
KY State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills54.0
Peer Average Days Supply1,603
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 53.6% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $294.18 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.63

State Avg Cost Per Claim

$41.58

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood.

Therapeutic Applications

Fenofibrate is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It works by increasing the natural substance (enzyme) that breaks down fats in the blood. Fenofibrate belongs to a group of drugs known as fibrates. Lowering triglycerides in people with very high triglyceride blood levels may decrease the risk of pancreas disease (pancreatitis). However, fenofibrate might not lower your risk of a heart attack or stroke. Talk to your doctor about the risks and benefits of fenofibrate. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Fiasp Flextouch

Generic Formulation: Insulin Aspart (Niacinamide)Specialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 14
30-Day Fills 23.7
Days Supply 710
KY State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills28.7
Peer Average Days Supply801
Conservative Utilization

This provider writes prescriptions for this formulation 26.3% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $12,579.55 across this reporting matrix range.

Provider Avg Cost Per Claim

$898.54

State Avg Cost Per Claim

$1,075.85

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Gabapentin

Generic Formulation: GabapentinSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 42
30-Day Fills 74.0
Days Supply 2,220
KY State Average Benchmarks
Peer Average Claims162.0
Peer Average 30-Day Fills192.6
Peer Average Days Supply5,572
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 74.1% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,034.61 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.63

State Avg Cost Per Claim

$15.61

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Glimepiride

Generic Formulation: GlimepirideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 196
30-Day Fills 530.2
Days Supply 15,879
KY State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills116.8
Peer Average Days Supply3,487
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 284.3% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,730.96 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.93

State Avg Cost Per Claim

$9.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the AMARYLLIDACEAE plant family.

Therapeutic Applications

Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Glipizide

Generic Formulation: GlipizideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 33
30-Day Fills 75.0
Days Supply 2,250
KY State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills85.1
Peer Average Days Supply2,535
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $308.25 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.34

State Avg Cost Per Claim

$6.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

Therapeutic Applications

Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Glyxambi

Generic Formulation: Empagliflozin/LinagliptinSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 12
30-Day Fills 34.0
Days Supply 1,020
KY State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills28.6
Peer Average Days Supply843
Conservative Utilization

This provider writes prescriptions for this formulation 40.0% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $21,564.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,797.07

State Avg Cost Per Claim

$855.55

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is a combination of 2 drugs: empagliflozin and linagliptin. It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Linagliptin works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes.

Gvoke Hypopen 2-Pack

Generic Formulation: GlucagonSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 12
30-Day Fills 14.7
Days Supply 217
KY State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills19.2
Peer Average Days Supply276
Conservative Utilization

This provider writes prescriptions for this formulation 33.3% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $9,474.56 across this reporting matrix range.

Provider Avg Cost Per Claim

$789.55

State Avg Cost Per Claim

$625.41

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Peptides derived from proglucagon which is also the precursor of pancreatic GLUCAGON. Despite expression of proglucagon in multiple tissues, the major production site of glucagon-like peptides (GLPs) is the INTESTINAL L CELLS. GLPs include glucagon-like peptide 1, glucagon-like peptide 2, and the various truncated forms.

Therapeutic Applications

This medication is the same as your body's own glucagon, a natural substance that raises blood sugar by causing the body to release sugar stored in the liver. It is used to treat very low blood sugar (hypoglycemia) that may cause you to need help from others. Make sure a family member or caregiver knows where you keep this medication and how to use it before you need their help.

Humalog

Generic Formulation: Insulin LisproSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 12
30-Day Fills 35.9
Days Supply 1,076
KY State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills37.8
Peer Average Days Supply1,004
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 53.8% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $25,902.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,158.58

State Avg Cost Per Claim

$903.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Humalog Kwikpen U-100

Generic Formulation: Insulin LisproSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 53
30-Day Fills 134.9
Days Supply 4,015
KY State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills46.6
Peer Average Days Supply1,278
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 89.3% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $106,990.42 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,018.69

State Avg Cost Per Claim

$967.68

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Humalog Kwikpen U-200

Generic Formulation: Insulin LisproSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 11
30-Day Fills 31.8
Days Supply 953
KY State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills27.7
Peer Average Days Supply782
Conservative Utilization

This provider writes prescriptions for this formulation 38.9% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $82,351.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$7,486.47

State Avg Cost Per Claim

$2,048.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Humulin R U-500

Generic Formulation: Insulin Regular, HumanSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 11
30-Day Fills 13.4
Days Supply 377
KY State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills44.7
Peer Average Days Supply1,248
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 68.6% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $21,373.91 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,943.08

State Avg Cost Per Claim

$1,984.55

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin).

Humulin R U-500 Kwikpen

Generic Formulation: Insulin Regular, HumanSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 28
30-Day Fills 40.8
Days Supply 1,128
KY State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills40.1
Peer Average Days Supply1,078
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $49,392.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,764.00

State Avg Cost Per Claim

$1,873.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin).

Hydrochlorothiazide

Generic Formulation: HydrochlorothiazideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 18
30-Day Fills 52.0
Days Supply 1,560
KY State Average Benchmarks
Peer Average Claims84.0
Peer Average 30-Day Fills188.6
Peer Average Days Supply5,636
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 78.6% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $110.67 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.15

State Avg Cost Per Claim

$4.31

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.

Therapeutic Applications

This medication is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Hydrochlorothiazide belongs to a class of drugs known as diuretics/water pills. It works by causing you to make more urine. This helps your body get rid of extra salt and water. This medication also reduces extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, or kidney disease. This can lessen symptoms such as shortness of breath or swelling in your ankles or feet.

Insulin Aspart Flexpen

Generic Formulation: Insulin AspartSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 17
30-Day Fills 37.9
Days Supply 1,136
KY State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills31.6
Peer Average Days Supply618
Conservative Utilization

This provider writes prescriptions for this formulation 32.0% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $10,711.92 across this reporting matrix range.

Provider Avg Cost Per Claim

$630.11

State Avg Cost Per Claim

$276.28

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

Therapeutic Applications

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Insulin Lispro

Generic Formulation: Insulin LisproSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 27
30-Day Fills 50.7
Days Supply 1,488
KY State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills28.3
Peer Average Days Supply713
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,324.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$234.23

State Avg Cost Per Claim

$235.46

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Insulin Lispro Kwikpen U-100

Generic Formulation: Insulin LisproSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 16
30-Day Fills 30.5
Days Supply 914
KY State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills33.0
Peer Average Days Supply790
Conservative Utilization

This provider writes prescriptions for this formulation 33.3% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $9,029.11 across this reporting matrix range.

Provider Avg Cost Per Claim

$564.32

State Avg Cost Per Claim

$209.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Invokana

Generic Formulation: CanagliflozinSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 20
30-Day Fills 22.0
Days Supply 660
KY State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills29.9
Peer Average Days Supply870
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $13,870.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$693.51

State Avg Cost Per Claim

$925.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A glucoside-derived SODIUM-GLUCOSE TRANSPORTER 2 inhibitor that stimulates urinary excretion of glucose by suppressing renal glucose reabsorption. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Canagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Canagliflozin is also used by people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Canagliflozin is also used by people with type 2 diabetes and kidney disease to lower the risk of dialysis, death from heart disease, and the need to go to the hospital for heart failure. Canagliflozin works by increasing the removal of sugar by your kidneys.

Janumet Xr

Generic Formulation: Sitagliptin Phos/Metformin HclSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 15
30-Day Fills 37.0
Days Supply 1,110
KY State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills37.4
Peer Average Days Supply1,112
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $21,232.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,415.52

State Avg Cost Per Claim

$943.57

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. This product contains 2 medications. Sitagliptin works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

Januvia

Generic Formulation: Sitagliptin PhosphateSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 50
30-Day Fills 100.2
Days Supply 3,005
KY State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills74.5
Peer Average Days Supply2,153
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $57,331.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,146.64

State Avg Cost Per Claim

$936.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.

Therapeutic Applications

Sitagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Sitagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes.

Jardiance

Generic Formulation: EmpagliflozinSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 166
30-Day Fills 396.9
Days Supply 11,877
KY State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills75.3
Peer Average Days Supply2,208
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 277.3% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $249,661.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,503.99

State Avg Cost Per Claim

$1,008.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys.

Lantus Solostar

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 149
30-Day Fills 371.1
Days Supply 11,033
KY State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills68.2
Peer Average Days Supply1,918
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 272.5% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $155,289.57 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,042.21

State Avg Cost Per Claim

$702.90

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Levemir Flexpen

Generic Formulation: Insulin DetemirSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 24
30-Day Fills 66.6
Days Supply 1,990
KY State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$1,347.43

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide).

Levothyroxine Sodium

Generic Formulation: Levothyroxine SodiumSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 363
30-Day Fills 987.0
Days Supply 29,588
KY State Average Benchmarks
Peer Average Claims174.0
Peer Average 30-Day Fills360.1
Peer Average Days Supply10,609
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 108.6% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,032.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.62

State Avg Cost Per Claim

$15.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

Therapeutic Applications

Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Lisinopril

Generic Formulation: LisinoprilSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 76
30-Day Fills 210.0
Days Supply 6,300
KY State Average Benchmarks
Peer Average Claims148.0
Peer Average 30-Day Fills325.5
Peer Average Days Supply9,708
Conservative Utilization

This provider writes prescriptions for this formulation 48.6% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $335.89 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.42

State Avg Cost Per Claim

$5.98

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure.

Therapeutic Applications

Lisinopril is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily.

Losartan Potassium

Generic Formulation: Losartan PotassiumSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 53
30-Day Fills 158.0
Days Supply 4,740
KY State Average Benchmarks
Peer Average Claims106.0
Peer Average 30-Day Fills240.4
Peer Average Days Supply7,172
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $912.89 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.22

State Avg Cost Per Claim

$10.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.

Therapeutic Applications

Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.

Losartan-Hydrochlorothiazide

Generic Formulation: Losartan/HydrochlorothiazideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 11
30-Day Fills 33.0
Days Supply 990
KY State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills84.3
Peer Average Days Supply2,523
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 67.6% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $266.14 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.19

State Avg Cost Per Claim

$16.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This drug is used to treat high blood pressure. It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains two medications: losartan and hydrochlorothiazide. Losartan is an angiotensin receptor blocker (ARB) and works by relaxing blood vessels so that blood can flow more easily. Hydrochlorothiazide is a water pill (diuretic) that causes you to make more urine, which helps your body get rid of extra salt and water.

Metformin Hcl

Generic Formulation: Metformin HclSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 230
30-Day Fills 621.0
Days Supply 18,576
KY State Average Benchmarks
Peer Average Claims108.0
Peer Average 30-Day Fills233.1
Peer Average Days Supply6,945
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 113.0% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,339.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.17

State Avg Cost Per Claim

$6.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Therapeutic Applications

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Metformin Hcl Er

Generic Formulation: Metformin HclSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 234
30-Day Fills 668.6
Days Supply 20,060
KY State Average Benchmarks
Peer Average Claims56.0
Peer Average 30-Day Fills129.5
Peer Average Days Supply3,872
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 317.9% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,130.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.38

State Avg Cost Per Claim

$9.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Therapeutic Applications

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Methimazole

Generic Formulation: MethimazoleSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 26
30-Day Fills 63.6
Days Supply 1,908
KY State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills62.3
Peer Average Days Supply1,849
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $468.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.01

State Avg Cost Per Claim

$10.81

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme.

Therapeutic Applications

Methimazole is used to treat overactive thyroid (hyperthyroidism). It works by stopping the thyroid gland from making too much thyroid hormone.

Metoprolol Succinate

Generic Formulation: Metoprolol SuccinateSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 21
30-Day Fills 63.0
Days Supply 1,890
KY State Average Benchmarks
Peer Average Claims109.0
Peer Average 30-Day Fills240.5
Peer Average Days Supply7,160
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 80.7% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $395.48 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.83

State Avg Cost Per Claim

$17.57

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.

Therapeutic Applications

This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.

Metoprolol Tartrate

Generic Formulation: Metoprolol TartrateSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 20
30-Day Fills 60.0
Days Supply 1,800
KY State Average Benchmarks
Peer Average Claims89.0
Peer Average 30-Day Fills177.6
Peer Average Days Supply5,246
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 77.5% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $104.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.21

State Avg Cost Per Claim

$6.09

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.

Therapeutic Applications

Metoprolol is used with or without other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication is also used to treat chest pain (angina) and to improve survival after a heart attack. Metoprolol belongs to a class of drugs known as beta blockers. It works by blocking the action of certain natural chemicals in your body, such as epinephrine, on the heart and blood vessels. This effect lowers the heart rate, blood pressure, and strain on the heart.

Mounjaro

Generic Formulation: TirzepatideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 96
30-Day Fills 142.7
Days Supply 4,150
KY State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills23.2
Peer Average Days Supply657
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 357.1% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $159,379.35 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,660.20

State Avg Cost Per Claim

$1,160.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A glucose-dependent insulinotropic polypeptide (GIP) receptor and Glucose-like peptide-1 (GLP-1) receptor agonist to enhance glycemic control in adults with TYPE 2 DIABETES MELLITUS.

Therapeutic Applications

Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes.

Nano 2nd Gen Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 83
30-Day Fills 189.5
Days Supply 5,564
KY State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills53.6
Peer Average Days Supply1,587
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 219.2% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $10,755.54 across this reporting matrix range.

Provider Avg Cost Per Claim

$129.58

State Avg Cost Per Claim

$86.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Nateglinide

Generic Formulation: NateglinideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 14
30-Day Fills 42.0
Days Supply 1,260
KY State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills55.0
Peer Average Days Supply1,630
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,287.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$163.41

State Avg Cost Per Claim

$76.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenylalanine and cyclohexane derivative that acts as a hypoglycemic agent by stimulating the release of insulin from the pancreas. It is used in the treatment of TYPE 2 DIABETES.

Therapeutic Applications

Nateglinide is used alone or with other medications to control high blood sugar along with a proper diet and exercise program. It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. It works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet.

Novolin N

Generic Formulation: Insulin Nph Human IsophaneSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 11
30-Day Fills 12.9
Days Supply 388
KY State Average Benchmarks
Peer Average Claims15.0
Peer Average 30-Day Fills20.8
Peer Average Days Supply566
Conservative Utilization

This provider writes prescriptions for this formulation 26.7% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,552.67 across this reporting matrix range.

Provider Avg Cost Per Claim

$504.79

State Avg Cost Per Claim

$463.37

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Novolog

Generic Formulation: Insulin AspartSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 17
30-Day Fills 35.1
Days Supply 1,048
KY State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills39.5
Peer Average Days Supply1,076
Conservative Utilization

This provider writes prescriptions for this formulation 41.4% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $28,544.47 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,679.09

State Avg Cost Per Claim

$940.38

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

Therapeutic Applications

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Novolog Flexpen

Generic Formulation: Insulin AspartSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 115
30-Day Fills 220.3
Days Supply 6,517
KY State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills51.7
Peer Average Days Supply1,402
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 248.5% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $202,521.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,761.06

State Avg Cost Per Claim

$966.70

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

Therapeutic Applications

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Olmesartan Medoxomil

Generic Formulation: Olmesartan MedoxomilSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 19
30-Day Fills 31.0
Days Supply 918
KY State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills73.7
Peer Average Days Supply2,207
Conservative Utilization

This provider writes prescriptions for this formulation 38.7% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $396.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.88

State Avg Cost Per Claim

$30.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to manage HYPERTENSION.

Therapeutic Applications

Olmesartan is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Olmesartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.

Omega-3 Acid Ethyl Esters

Generic Formulation: Omega-3 Acid Ethyl EstersSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 28
30-Day Fills 56.0
Days Supply 1,680
KY State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills34.4
Peer Average Days Supply1,021
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 33.3% more claims than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,373.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$84.76

State Avg Cost Per Claim

$69.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Omega-3 acid ethyl esters, a type of fat found in fish oil, is used along with diet and exercise to help lower levels of a certain blood fat (triglyceride). It may also raise good cholesterol (HDL). In general, this drug is used after your blood fat levels have not been fully controlled by non-drug treatments (such as diet changes, exercise, decreasing alcohol intake, weight loss if overweight, controlling blood sugar if diabetic, and regulating your thyroid hormone levels). Lowering triglycerides and increasing good cholesterol may help decrease the risk for strokes and heart attacks. Omega-3 acid ethyl esters are thought to work by decreasing the amount of triglyceride the body makes.

Omnipod 5 G6 Pods (Gen 5)

Generic Formulation: Insulin Pump Cart,automated,btSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 23
30-Day Fills 25.0
Days Supply 750
KY State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills41.3
Peer Average Days Supply1,215
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $17,882.69 across this reporting matrix range.

Provider Avg Cost Per Claim

$777.51

State Avg Cost Per Claim

$1,529.43

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ozempic

Generic Formulation: SemaglutideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 225
30-Day Fills 416.3
Days Supply 12,273
KY State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills57.0
Peer Average Days Supply1,658
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 462.5% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $424,726.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,887.67

State Avg Cost Per Claim

$1,325.69

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment.

Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 13
30-Day Fills 18.5
Days Supply 524
KY State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills31.8
Peer Average Days Supply933
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $418.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$32.19

State Avg Cost Per Claim

$27.69

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Pioglitazone Hcl

Generic Formulation: Pioglitazone HclSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 171
30-Day Fills 483.2
Days Supply 14,466
KY State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills90.1
Peer Average Days Supply2,694
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 338.5% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,976.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.41

State Avg Cost Per Claim

$19.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Pioglitazone is a diabetes drug (thiazolidinedione-type, also called glitazones) used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. It works by helping to restore your body's proper response to insulin, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone is used either alone or in combination with other diabetes medications (such as metformin or a sulfonylurea such as glyburide). Talk to your doctor about the risks and benefits of pioglitazone.

Pravastatin Sodium

Generic Formulation: Pravastatin SodiumSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 52
30-Day Fills 157.3
Days Supply 4,720
KY State Average Benchmarks
Peer Average Claims68.0
Peer Average 30-Day Fills160.5
Peer Average Days Supply4,792
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $798.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.36

State Avg Cost Per Claim

$16.01

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES).

Therapeutic Applications

Pravastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Repatha Sureclick

Generic Formulation: EvolocumabSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 24
30-Day Fills 40.2
Days Supply 1,176
KY State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills45.6
Peer Average Days Supply1,318
Conservative Utilization

This provider writes prescriptions for this formulation 27.3% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $24,705.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,029.41

State Avg Cost Per Claim

$763.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Evolocumab is used along with a proper diet to help lower bad cholesterol (LDL) in the blood. It may be used with other LDL-lowering treatments (such as statin drugs, ezetimibe, LDL apheresis). Evolocumab is also used by people who have heart disease to help prevent heart attacks and strokes. This medication belongs to a class of drugs known as monoclonal antibodies. It works by improving how well your body gets rid of LDL cholesterol. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Rosuvastatin Calcium

Generic Formulation: Rosuvastatin CalciumSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 161
30-Day Fills 479.0
Days Supply 14,370
KY State Average Benchmarks
Peer Average Claims96.0
Peer Average 30-Day Fills223.2
Peer Average Days Supply6,669
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 67.7% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,639.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.39

State Avg Cost Per Claim

$22.37

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES.

Therapeutic Applications

Rosuvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Talk with your doctor for more details.

Simvastatin

Generic Formulation: SimvastatinSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 22
30-Day Fills 66.0
Days Supply 1,980
KY State Average Benchmarks
Peer Average Claims82.0
Peer Average 30-Day Fills191.5
Peer Average Days Supply5,720
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 73.2% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $227.37 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.34

State Avg Cost Per Claim

$7.53

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL CHOLESTEROL.

Therapeutic Applications

Simvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Soliqua 100-33

Generic Formulation: Insulin Glargine/LixisenatideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 14
30-Day Fills 27.7
Days Supply 811
KY State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills39.6
Peer Average Days Supply1,129
Conservative Utilization

This provider writes prescriptions for this formulation 48.1% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $22,157.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,582.68

State Avg Cost Per Claim

$1,035.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is a combination of insulin glargine and lixisenatide and is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Lixisenatide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high sugar levels (such as after a meal) and decreasing the amount of sugar your liver makes.

Spironolactone

Generic Formulation: SpironolactoneSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 11
30-Day Fills 21.0
Days Supply 630
KY State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills90.5
Peer Average Days Supply2,691
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 75.0% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $451.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$41.01

State Avg Cost Per Claim

$11.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)

Therapeutic Applications

Spironolactone is used to treat high blood pressure and heart failure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (such as heart failure, liver disease) by removing excess fluid and improving symptoms such as breathing problems. This medication is also used to treat conditions in which the body is making too much of a natural substance (aldosterone). Spironolactone is known as a water pill (potassium-sparing diuretic).

Synthroid

Generic Formulation: Levothyroxine SodiumSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 39
30-Day Fills 117.0
Days Supply 3,510
KY State Average Benchmarks
Peer Average Claims43.0
Peer Average 30-Day Fills106.1
Peer Average Days Supply3,170
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,694.87 across this reporting matrix range.

Provider Avg Cost Per Claim

$43.46

State Avg Cost Per Claim

$59.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

Therapeutic Applications

Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Toujeo Max Solostar

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 42
30-Day Fills 68.8
Days Supply 1,980
KY State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills46.9
Peer Average Days Supply1,347
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 61.5% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $115,300.66 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,745.25

State Avg Cost Per Claim

$1,273.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Toujeo Solostar

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 69
30-Day Fills 164.9
Days Supply 4,948
KY State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills40.1
Peer Average Days Supply1,135
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 187.5% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $67,597.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$979.67

State Avg Cost Per Claim

$813.05

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Tradjenta

Generic Formulation: LinagliptinSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 14
30-Day Fills 22.0
Days Supply 660
KY State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills42.7
Peer Average Days Supply1,147
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 53.3% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $12,364.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$883.20

State Avg Cost Per Claim

$687.62

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.

Therapeutic Applications

Linagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Linagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes.

Tresiba Flextouch U-100

Generic Formulation: Insulin DegludecSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 35
30-Day Fills 106.2
Days Supply 3,184
KY State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills46.1
Peer Average Days Supply1,312
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 34.6% more claims than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $20,610.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$588.87

State Avg Cost Per Claim

$765.18

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

Tresiba Flextouch U-200

Generic Formulation: Insulin DegludecSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 89
30-Day Fills 184.5
Days Supply 5,504
KY State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills48.5
Peer Average Days Supply1,381
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 196.7% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $165,547.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,860.08

State Avg Cost Per Claim

$1,298.80

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

Trulicity

Generic Formulation: DulaglutideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 97
30-Day Fills 169.0
Days Supply 4,966
KY State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills60.5
Peer Average Days Supply1,729
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 131.0% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $172,420.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,777.53

State Avg Cost Per Claim

$1,356.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment.

Ultra-Fine Nano Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 32
30-Day Fills 72.8
Days Supply 2,164
KY State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills38.6
Peer Average Days Supply1,127
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 45.5% more claims than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,196.81 across this reporting matrix range.

Provider Avg Cost Per Claim

$68.65

State Avg Cost Per Claim

$72.89

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Vascepa

Generic Formulation: Icosapent EthylSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 22
30-Day Fills 48.0
Days Supply 1,438
KY State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills43.0
Peer Average Days Supply1,246
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $18,226.09 across this reporting matrix range.

Provider Avg Cost Per Claim

$828.46

State Avg Cost Per Claim

$498.76

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Icosapent ethyl is used along with certain other cholesterol medications (statins such as atorvastatin, simvastatin) to reduce the risk of heart attack, stroke, and certain types of heart problems that require treatment in a hospital. It is also used along with a proper diet to help lower fats (triglycerides) in the blood. Icosapent ethyl is a type of omega-3 fatty acid, a fat found in fish oil. It is thought to work by decreasing the amount of triglycerides made by the body. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Victoza 3-Pak

Generic Formulation: LiraglutideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 19
30-Day Fills 45.0
Days Supply 1,350
KY State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills30.1
Peer Average Days Supply899
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $53,860.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,834.76

State Avg Cost Per Claim

$1,676.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.

Therapeutic Applications

This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite.

Vitamin D2

Generic Formulation: Ergocalciferol (Vitamin D2)Specialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 17
30-Day Fills 24.2
Days Supply 700
KY State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills41.0
Peer Average Days Supply1,195
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $75.41 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.44

State Avg Cost Per Claim

$8.01

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24.

Therapeutic Applications

Vitamin D (ergocalciferol-D2, cholecalciferol-D3, alfacalcidol) is a fat-soluble vitamin that helps your body absorb calcium and phosphorus. Having the right amount of vitamin D, calcium, and phosphorus is important for building and keeping strong bones. Vitamin D is used to treat and prevent bone disorders (such as rickets, osteomalacia). Vitamin D is made by the body when skin is exposed to sunlight. Sunscreen, protective clothing, limited exposure to sunlight, dark skin, and age may prevent getting enough vitamin D from the sun. Vitamin D with calcium is used to treat or prevent bone loss (osteoporosis). Vitamin D is also used with other medications to treat low levels of calcium or phosphate caused by certain disorders (such as hypoparathyroidism, pseudohypoparathyroidism, familial hypophosphatemia). It may be used in kidney disease to keep calcium levels normal and allow normal bone growth. Vitamin D drops (or other supplements) are given to breast-fed infants because breast milk usually has low levels of vitamin D.

Xigduo Xr

Generic Formulation: Dapaglifloz Propaned/MetforminSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 11
30-Day Fills 23.0
Days Supply 690
KY State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills47.5
Peer Average Days Supply1,415
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 63.3% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $13,855.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,259.61

State Avg Cost Per Claim

$870.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is a combination of 2 drugs: dapagliflozin and metformin. It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used to treat kidney disease or heart failure in people with type 2 diabetes. It may help you live longer and lower your risk of going to the hospital for heart failure. This medication works by helping to restore your body's proper response to the insulin you naturally produce. It also increases the removal of sugar by your kidneys, decreases how much sugar is made in your liver, and decreases how much sugar your body takes in through your stomach and intestines.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like REBECCA LYNN FLORA APRN provides transparency into local medical care patterns within Covington, KY.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Nurse Practitioner** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.